Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 20
1989 55
1990 67
1991 71
1992 100
1993 111
1994 128
1995 118
1996 115
1997 128
1998 115
1999 148
2000 128
2001 148
2002 114
2003 128
2004 138
2005 157
2006 162
2007 153
2008 134
2009 127
2010 156
2011 151
2012 129
2013 120
2014 130
2015 128
2016 110
2017 95
2018 66
2019 66
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

3,453 results
Results by year
Filters applied: . Clear all
Page 1
TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG.
Leong T, Smithers BM, Haustermans K, Michael M, Gebski V, Miller D, Zalcberg J, Boussioutas A, Findlay M, O'Connell RL, Verghis J, Willis D, Kron T, Crain M, Murray WK, Lordick F, Swallow C, Darling G, Simes J, Wong R. Leong T, et al. Ann Surg Oncol. 2017 Aug;24(8):2252-2258. doi: 10.1245/s10434-017-5830-6. Epub 2017 Mar 23. Ann Surg Oncol. 2017. PMID: 28337660 Clinical Trial.
Epirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue Sarcomas.
Lu E, Perlewitz KS, Hayden JB, Hung AY, Doung YC, Davis LE, Mansoor A, Vetto JT, Billingsley KG, Kaempf A, Park B, Ryan CW. Lu E, et al. Ann Surg Oncol. 2018 Apr;25(4):920-927. doi: 10.1245/s10434-018-6346-4. Epub 2018 Jan 31. Ann Surg Oncol. 2018. PMID: 29388122 Clinical Trial.
Loading, release and stability of epirubicin-loaded drug-eluting beads.
Spindeldreier KC, Thiesen J, Krämer I. Spindeldreier KC, et al. J Oncol Pharm Pract. 2016 Aug;22(4):591-8. doi: 10.1177/1078155215594416. Epub 2015 Jul 8. J Oncol Pharm Pract. 2016. PMID: 26160072
Weekly administration of docetaxel and epirubicin as first-line treatment for hormone-refractory prostate carcinoma.
Neri B, Molinara E, Pantaleo P, Rangan S, Crisci A, Della Melina A, Raugei A, Villari D, Nicitat G. Neri B, et al. Oncol Res. 2009;17(11-12):565-70. doi: 10.3727/096504009789745539. Oncol Res. 2009. PMID: 19806787
Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial.
Blohmer JU, Schmid P, Hilfrich J, Friese K, Kleine-Tebbe A, Koelbl H, Sommer H, Morack G, Wischnewsky MB, Lichtenegger W, Kuemmel S. Blohmer JU, et al. Ann Oncol. 2010 Jul;21(7):1430-1435. doi: 10.1093/annonc/mdp585. Epub 2010 Jan 20. Ann Oncol. 2010. PMID: 20089562 Free article. Clinical Trial.
Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer.
Taucher S, Rudas M, Mader RM, Gnant M, Sporn E, Dubsky P, Roka S, Bachleitner T, Fitzal F, Kandioler D, Wenzel C, Steger GG, Mittlböck M, Jakesz R. Taucher S, et al. Breast Cancer Res Treat. 2003 Dec;82(3):207-13. doi: 10.1023/B:BREA.0000004378.15859.51. Breast Cancer Res Treat. 2003. PMID: 14703068
Gemcitabine and epirubicin in patients with metastatic breast cancer: a phase I/II study.
Campone M, Fumoleau P, Viens P, Diéras V, Pujade-Lauraine E, Serin D, Petit T, Espié M, Kayitalire L, Bozec L, Pouillart P. Campone M, et al. Breast. 2006 Oct;15(5):601-9. doi: 10.1016/j.breast.2005.11.010. Breast. 2006. PMID: 17045160 Clinical Trial.
Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group.
Mavroudis D, Saloustros E, Boukovinas I, Papakotoulas P, Kakolyris S, Ziras N, Christophylakis C, Kentepozidis N, Fountzilas G, Rigas G, Varthalitis I, Kalbakis K, Agelaki S, Hatzidaki D, Georgoulias V. Mavroudis D, et al. Br J Cancer. 2017 Jul 11;117(2):164-170. doi: 10.1038/bjc.2017.158. Epub 2017 Jun 22. Br J Cancer. 2017. PMID: 28641315 Free PMC article. Clinical Trial.
Combined 5-fluorouracil infusion with fractionated epirubicin and cyclophosphamide in advanced breast cancer.
Recchia F, De Filippis S, Rosselli M, Saggio G, Pompili P, Piccinini M, Rea S. Recchia F, et al. Am J Clin Oncol. 2001 Aug;24(4):392-6. doi: 10.1097/00000421-200108000-00018. Am J Clin Oncol. 2001. PMID: 11474271 Clinical Trial.
Docetaxel and epirubicin in advanced breast cancer.
Sessa C, Pagani O. Sessa C, et al. Oncologist. 2001;6 Suppl 3:13-6. doi: 10.1634/theoncologist.6-suppl_3-13. Oncologist. 2001. PMID: 11346679 Free article. Review.
3,453 results
Jump to page
Feedback